Volume 16 Supplement 1

Abstracts from the 7th International Conference on cGMP Generators, Effectors and Therapeutic Implications

Meeting abstracts

Edited by Johannes-Peter Stasch, John Burnett, Harald Schmidt, Michaela Kuhn and Franz Hofmann

Publication of this supplement has been fully funded by FEBGLA e.V. Johannes-Peter Stasch is an employee of Bayer Pharma AG, Wuppertal, Germany. He holds many patents on sGC stimulators and sGC activators. John C Burnett Jr is the chairman of the advisory board for Nile Therapeutics and is a Co-Founder and the Chief Scientific Officer for Zumbro Discovery. Mayo Clinic has licensed CD-NP to Nile Therapeutics and MANP to Zumbro Discovery. The other Supplement Editors declare that they have no competing interests.

7th International Conference on cGMP Generators, Effectors and Therapeutic Implications. Go to conference site.

Trier, Germany19-21 June 2015

Concatenated PDF V16 S1

Page 3 of 3

Interaction of cCMP with the cGK, cAK and MAPK kinases in murine tissues

Authors: Stefanie Wolfertstetter, Frank Schwede, Franz Hofmann and Jens Schlossmann

Citation: BMC Pharmacology and Toxicology 2015 16(Suppl 1):A101

Content type: Meeting abstract Published on: 2 September 2015
- View Full Text
- View PDF
The role of particulate guanylyl cyclase B (GC-B) in auditory function in adult mice

Authors: Steffen Wolter, Dorit Möhrle, Dennis Zelle, Marlies Knipper, Hannes Schmidt and Lukas Rüttiger

Citation: BMC Pharmacology and Toxicology 2015 16(Suppl 1):A102

Content type: Meeting abstract Published on: 2 September 2015
- View Full Text
- View PDF
C-type natriuretic peptide/guanylyl cyclase-B (GC-B) system attenuates proliferation of rhabdomyosarcoma in combination with sildenafil: A novel anticancer therapy

Authors: Masahiro Zenitani, Shuichiro Uehara, Toru Kimura, Takashi Nojiri, Koichi Miura, Hiroshi Hosoda, Mikiya Miyazato, Hiroomi Okuyama and Kenji Kangawa

Citation: BMC Pharmacology and Toxicology 2015 16(Suppl 1):A103

Content type: Meeting abstract Published on: 2 September 2015
- View Full Text
- View PDF
C-type natriuretic peptide chronic administration attenuates cardiac fibrosis and inflammation in spontaneously hypertensive rats

Authors: E Santos Prentki, C Caniffi, G Bouchet, D Maglio González, J Toblli, MA Costa and C Arranz

Citation: BMC Pharmacology and Toxicology 2015 16(Suppl 1):A104

Content type: Meeting abstract Published on: 2 September 2015
- View Full Text
- View PDF

Abstracts from the 7th International Conference on cGMP Generators, Effectors and Therapeutic Implications

Meeting abstracts

Interaction of cCMP with the cGK, cAK and MAPK kinases in murine tissues

The role of particulate guanylyl cyclase B (GC-B) in auditory function in adult mice

C-type natriuretic peptide/guanylyl cyclase-B (GC-B) system attenuates proliferation of rhabdomyosarcoma in combination with sildenafil: A novel anticancer therapy

C-type natriuretic peptide chronic administration attenuates cardiac fibrosis and inflammation in spontaneously hypertensive rats

Important information

Annual Journal Metrics

Peer-review Terminology

Follow

BMC Pharmacology and Toxicology

Contact us